Moderna’s COVID-19 vaccine has reached another significant moment.A panel affirmed by a vote Thursday that based on the totality of scientific evidence available, the benefits of the Moderna COVID-19 vaccine outweigh its risks for use in individuals 18 and older.The head of the Food and Drug Administration also said late Thursday that his agency will move to quickly authorize the second COVID-19 vaccine to fight